Home
Conditions
Opioid-Induced Constipation

Clinical trial condition

Opioid-Induced Constipation

Explore clinical trials studying Opioid-Induced Constipation. Study availability and eligibility vary by location and protocol.

65 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Opioid-Induced Constipation trial results

Recruiting

Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids

NCT05588323

Conditions: Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations: University Center Mother Theresa , Hospital - Onco-hematology department Tirana, Albania

Yeolyan Hematology. , and Oncology Center - Yerevan, Armenia

CHU Saint-Pierre Clinical Trials Unit Brussels, Belgium

Universitair Ziekenhuis Brussel (UZBrussel) - Department of Anesthesiology and Perioperative Medicine Brussels, Belgium

View all 16 locations

View Trial Details

Recruiting

Naldemedine in Clinical Practice in Cancer Patients With Opioid Induced CONstipation: Clinical Outcomes and Patient Experience

NCT07231796

Conditions: Cancer, Chemically-Induced Disorders, Constipation, +9 more
Locations: Amsterdam UMC Amsterdam, Netherlands

View Trial Details

Recruiting

Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation

NCT03720613

Conditions: Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations: Research Site Wilmington, Delaware, United States

View Trial Details

Recruiting

Prevention of Opioid-induced Constipation in Patients With Advanced Cancer

NCT05216328

Conditions: Cancer Pain, Chemically-Induced Disorders, Constipation, +11 more
Locations: Flevoziekenhuis Almere Stad, Flevoland, Netherlands

Rijnstate Ziekenhuis Arnhem, Gelderland, Netherlands

Radboud university Medical center Nijmegen Nijmegen, Gelderland, Netherlands

Jeroen Bosch Ziekenhuis 's-Hertogenbosch, North Brabant, Netherlands

View all 13 locations

View Trial Details

Not Yet Recruiting

Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain

NCT06897917

Conditions: Cancer Pain, Chemically-Induced Disorders, Constipation, +11 more
Locations: Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Completed

TD-1211 Single-Dose Study in Elderly and Young Healthy Subjects

NCT01655771

Conditions: Chemically-Induced Disorders, Constipation, Mental Disorders, +6 more
Locations: ICON Development Solutions San Antonio, Texas, United States

View Trial Details

Completed

A Study to Assess the Safety, Tolerability and Clinical Activity of TD-1211 in Patients With Opioid-Induced Constipation

NCT01333540

Conditions: Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations: Clinical Research Unit Salt Lake City, Utah, United States

View Trial Details

Completed

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation

NCT01459926

Conditions: Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations: G and L Research, LLC Foley, Alabama, United States

View Trial Details

Completed

A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation

NCT01040637

Conditions: Chemically-Induced Disorders, Constipation, Healthy, +8 more
Locations: Clinical Research Unit Pasadena, California, United States

Clinical Research Unit San Antonio, Texas, United States

Clinical Research Unit Salt Lake City, Utah, United States

View Trial Details

Completed

A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)

NCT01401985

Conditions: Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations: Theravance Biopharma Investigational Site Pasadena, California, United States

View Trial Details

Opioid-Induced Constipation

Opioid-Induced Constipation trial results

Related conditions